Breast carcinoma progression and Tumour vascular markers related to apoptotic mechanisms

Disease Markers

Volumn 2014, Issue , 2014, Pages

  Bilecova Rabajdova, Miroslava ^a   Urban, Peter ^a   Gregova, Kristina ^a   Varga, Jan ^a   Fialkovicová, Viera ^a   Kruzliak, Peter ^b   Marekova, Maria ^a  

^a P J AFÁRIK UNIVERSITY   (Slovakia)

^b ST ANNE S UNIVERSITY HOSPITAL   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; CYTOKINE RECEPTOR; CYTOSTATIC AGENT; DEATH RECEPTOR 6; GLYCOPROTEIN; GLYCOPROTEIN M6 B; MESSENGER RNA; TUMOR MARKER; UNCLASSIFIED DRUG; ACTIN; GPM6B PROTEIN, HUMAN; MEMBRANE PROTEIN; NERVE PROTEIN; TNFRSF21 PROTEIN, HUMAN; TUMOR NECROSIS FACTOR RECEPTOR;

ADULT; APOPTOSIS; ARTICLE; BREAST CARCINOMA; CANCER GROWTH; CANCER STAGING; CARCINOMA IN SITU; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRADUCTAL CARCINOMA; MAJOR CLINICAL STUDY; MIDDLE AGED; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR VASCULARIZATION; BLOOD; BREAST TUMOR; CANCER GRADING; CASE CONTROL STUDY; DISEASE COURSE; FEMALE; GENETICS; LUNG CARCINOMA; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); PAGET NIPPLE DISEASE; PATHOLOGY; VASCULARIZATION;

ACTINS; ADULT; APOPTOSIS; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; CASE-CONTROL STUDIES; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION; HUMANS; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; NEOPLASM GRADING; NEOVASCULARIZATION, PATHOLOGIC; NERVE TISSUE PROTEINS; RECEPTORS, TUMOR NECROSIS FACTOR; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL;

EID: 84896952651     PISSN: 02780240     EISSN: 18758630     Source Type: Journal    
DOI: 10.1155/2014/156034     Document Type: Article

References (29)

1. Sarkar S., Mandal M., Growth factor receptors and apoptosis regulators: signaling pathways, prognosis, chemosensitivity and treatment outcomes of breast cancer. Breast Cancer 2009 3 1 47 60 2-s2.0-77953396511
2. Liu W., Ahmad S. A., Reinmuth N., Shaheen R. M., Jung Y. D., Fan F., Ellis L. M., Endothelial cell survival and apoptosis in the tumor vasculature. Apoptosis 2000 5 4 323 328 2-s2.0-0033761908 10.1023/A:1009679307513
3. Seaman S., Stevens J., Yang M. Y., Logsdon D., Graff-Cherry C., St. Croix B., Genes that distinguish physiological and pathological angiogenesis. Cancer Cell 2007 11 6 539 554 2-s2.0-34249822498 10.1016/j.ccr.2007.04.017
4. MacFadyen J. R., Haworth O., Roberston D., Hardie D., Webster M.-T., Morris H. R., Panico M., Sutton-Smith M., Dell A., Van Der Geer P., Wienke D., Buckley C. D., Isacke C. M., Endosialin (TEM1, CD248) is a marker of stromal fibroblasts and is not selectively expressed on tumour endothelium. FEBS Letters 2005 579 12 2569 2575 2-s2.0-20944451492 10.1016/j.febslet.2005.03.071
5. Buckanovich R. J., Sasaroli D., O'Brien-Jenkins A., Botbyl J., Hammond R., Katsaros D., Sandaltzopoulos R., Liotta L. A., Gimotty P. A., Coukos G., Tumor vascular proteins as biomarkers in ovarian cancer. Journal of Clinical Oncology 2007 25 7 852 861 2-s2.0-33947545030 10.1200/JCO.2006.08.8583
6. Fesik S. W., Promoting apoptosis as a strategy for cancer drug discovery. Nature Reviews Cancer 2005 5 11 876 885 2-s2.0-28544443984 10.1038/nrc1736
7. Vouyiouklis D. A., Werner H., Griffiths I. R., Stewart G. J., Armin-Nave K., Thomson C. E., Molecular cloning and transfection studies of M6b-2, a novel splice variant of a member of the PLP-DM20/M6 gene family. Journal of Neuroscience Research 1998 52 633 640
8. Wu D.-F., Koch T., Liang Y.-J., Stumm R., Schulz S., Schröder H., Höllt V., Membrane glycoprotein M6a interacts with the -opioid receptor and facilitates receptor endocytosis and recycling. Journal of Biological Chemistry 2007 282 30 22239 22247 2-s2.0-34547581105 10.1074/jbc.M700941200
9. Nadon N. L., Miller S., Draeger K., Salvaggio M., Myelin proteolipid DM20: evidence for function independent of myelination. International Journal of Developmental Neuroscience 1997 15 3 285 293 2-s2.0-0030743093 10.1016/S0736-5748(97)00009-9
10. Fjorback A. W., Müller H. K., Wiborg O., Membrane glycoprotein M6B interacts with the human serotonin transporter. Journal of Molecular Neuroscience 2009 37 3 191 200 2-s2.0-62149116565 10.1007/s12031-008-9092-4
11. Pai V. P., Horseman N. D., Biphasic regulation of mammary epithelial resistance by serotonin through activation of multiple pathways. Journal of Biological Chemistry 2008 283 45 30901 30910 2-s2.0-57649178328 10.1074/jbc.M802476200
12. Pai V. P., Marshall A. M., Hernandez L. L., Buckley A. R., Horseman N. D., Altered serotonin physiology in human breast cancers favors paradoxical growth and cell survival. Breast Cancer Research 2009 11 6, article R81 2-s2.0-77954600574 10.1186/bcr2448
13. Guicciardi M. E., Gores G. J., Life and death by death receptors. The FASEB Journal 2009 23 6 1625 1637 2-s2.0-67649386107 10.1096/fj.08-111005
14. Benschop R., Wei T., Na S., Tumor necrosis factor receptor superfamily member 21: TNFR-related death receptor-6, DR6. Advances in Experimental Medicine and Biology 2009 647 186 194 2-s2.0-77953702982 10.1007/978-0-387-89520-8-13
15. Zeng L., Li T., Xu D. C., Death receptor 6 induces apoptosis not through type I or type II pathways, but via a unique mitochondria-dependent pathway by interacting with Bax protein. The Journal of Biological Chemistry 2012 287 29125 29133
16. Naik E., O'Reilly L. A., Asselin-Labat M.-L., Merino D., Lin A., Cook M., Coultas L., Bouillet P., Adams J. M., Strasser A., Destruction of tumor vasculature and abated tumor growth upon VEGF blockade is driven by proapoptotic protein Bim in endothelial cells. Journal of Experimental Medicine 2011 208 7 1351 1358 2-s2.0-79960370837 10.1084/jem.20100951
17. Gerber H.-P., Dixit V., Ferrara N., Vascular endothelial growth factor induces expression of the antiapoptotic proteins Bcl-2 and A1 in vascular endothelial cells. Journal of Biological Chemistry 1998 273 21 13313 13316 2-s2.0-0032557564 10.1074/jbc.273.21.13313
18. Gupta K., Kshirsagar S., Li W., Gui L., Ramakrishnan S., Gupta P., Law P. Y., Hebbel R. P., VEGF prevents apoptosis of human microvascular endothelial cells via opposing effects on MAPK/ERK and SAPK/JNK signaling. Experimental Cell Research 1999 247 2 495 504 2-s2.0-0033558798 10.1006/excr.1998.4359
19. Tartaglia L. A., Goeddel D. V., Tumor necrosis factor receptor signaling. A dominant negative mutation suppresses the activation of the 55-kDa tumor necrosis factor receptor. Journal of Biological Chemistry 1992 267 7 4304 4307 2-s2.0-0026744103
20. Ashkenazi A., Holland P., Eckhardt S. G., Ligand-based targeting of apoptosis in cancer: the potential of recombinant human apoptosis ligand 2/tumor necrosis factor-related apoptosis-inducing ligand (rhApo2L/TRAIL). Journal of Clinical Oncology 2008 26 21 3621 3630 2-s2.0-49049086338 10.1200/JCO.2007.15. 7198
21. Herbst R. S., Kurzrock R., Hong D. S., Valdivieso M., Hsu C.-P., Goyal L., Juan G., Hwang Y. C., Wong S., Hill J. S., Friberg G., LoRusso P. M., A first-in-human study of conatumumab in adult patients with advanced solid tumors. Clinical Cancer Research 2010 16 23 5883 5891 2-s2.0-78650340456 10.1158/1078-0432.CCR-10-0631
22. Kasof G. M., Lu J. J., Liu D., Speer B., Mongan K. N., Gomes B. C., Lorenzi M. V., Tumor necrosis factor- α induces the expression of DR6, a member of the TNF receptor family, through activation of NF- B. Oncogene 2001 20 55 7965 7975 2-s2.0-0035969635 10.1038/sj/onc/1204985
23. Schulze-Osthoff K., Ferrari D., Los M., Wesselborg S., Peter M. E., Apoptosis signaling by death receptors. European Journal of Biochemistry 1998 254 3 439 459 2-s2.0-0032526268
24. Tam E. M., Morrison C. J., Wu Y. I., Stack M. S., Overall C. M., Membrane protease proteomics: isotope-coded affinity tag MS identification of undescribed MT1-matrix metalloproteinase substrates. Proceedings of the National Academy of Sciences of the United States of America 2004 101 18 6917 6922 2-s2.0-2342460878 10.1073/pnas.0305862101
25. Têtu B., Brisson J., Wang C. S., Lapointe H., Beaudry G., Blanchette C., Trudel D., The influence of MMP-14, TIMP-2 and MMP-2 expression on breast cancer prognosis. Breast Cancer Research 2006 8 3, article R28 2-s2.0-33745157557 10.1186/bcr1503
26. Yang K., Mooney C., Spahlinger G., Schuetze S., Arias-Pulido H., Verschraegen C., Gimotty P., Buckanovich R. J., DR6 as a diagnostic and predictive biomarker in adult sarcoma. PLoS ONE 2012 7 5 2-s2.0-84860434781 10.1371/journal.pone.0036525 e36525
27. Lin E. Y., Li J.-F., Gnatovskiy L., Deng Y., Zhu L., Grzesik D. A., Qian H., Xue X.-N., Pollard J. W., Macrophages regulate the angiogenic switch in a mouse model of breast cancer. Cancer Research 2006 66 23 11238 11246 2-s2.0-33845767868 10.1158/0008-5472.CAN-06-1278
28. Houghton A. M., Grisolano J. L., Baumann M. L., Kobayashi D. K., Hautamaki R. D., Nehring L. C., Cornelius L. A., Shapiro S. D., Macrophage elastase (matrix metalloproteinase-12) suppresses growth of lung metastases. Cancer Research 2006 66 12 6149 6155 2-s2.0-33745700206 10.1158/0008-5472.CAN- 04-0297
29. Dong Z., Kumar R., Yang X., Fidler I. J., Macrophage-derived metalloelastase is responsible for the generation of angiostatin in Lewis lung carcinoma. Cell 1997 88 6 801 810 2-s2.0-0030998660 10.1016/S0092-8674(00)81926- 1